Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer

Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer

US Patent 11572405 · Granted Feb 7, 2023

Estimated economic value: $934,217,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition comprising tizoxanide and pharmaceutical use thereof2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containin2025
Peptide oligonucleotide conjugates2025
Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods o2023
Peptide oligonucleotide conjugates2023
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Cyanobacteria having improved photosynthetic activity2022
Methods of treating diseases associated with fibrosis using modified FGF-21 poly2022
Functionally-modified oligonucleotides and subunits thereof2021
Peptide oligonucleotide conjugates2021
Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods o2021
Cyanobacteria having improved photosynthetic activity2020